跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Neurofibromin
首页
药物
Neurofibromin
Neurofibromin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
TARGETED GENOMIC INTEGRATION TO RESTORE NEUROFIBROMIN CODING SEQUENCE IN NEUROFIBROMATOSIS TYPE 1 (NF1)
EP 4125350 A1
申请人: UNIV DUKE
优先权: 2020
EP
US
WO
3 件公开
Method of administration and treatment
US 9192604 B2
申请人: AUGER KURT R
优先权: 2012
CN
US
3 件公开
AAV vectors encoding NF1 and uses thereof
US 11401531 B2
申请人: UNIV MASSACHUSETTS
优先权: 2020
US
WO
3 件公开
MATERIALS AND METHODS FOR THE TREATMENT OF NEUROFIBROMIN 1 MUTATIONS AND DISEASES RESULTING THEREFROM
EP 4727966 A1
申请人: RES INST NATIONWIDE CHILDRENS HOSPITAL
优先权: 2023
EP
WO
2 件公开
Neurofibromin pathway modulators
US 8101606 B2
申请人: GUTMANN DAVID
优先权: 2008
US
2 件公开
Increase of protein synthesis ameliorates synaptopathy-related neurological disorders
US 10034848 B2
申请人: ACADEMIA SINICA
优先权: 2015
US
Method for the treatment of NF1- or RAS-associated disorders
US 9775833 B2
申请人: DARTMOUTH COLLEGE
优先权: 2016
US
Method for prevention or treatment of amyotrophic lateral sclerosis by administering gastrodin
US 11963969 B2
申请人: BUDDHIST TZU CHI MEDICAL FOUND
优先权: 2021
US
药物
反馈